Vaughan Nelson Investment Management L.P. Has $497,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Vaughan Nelson Investment Management L.P. reduced its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 27.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 985 shares of the healthcare conglomerate’s stock after selling 380 shares during the period. Vaughan Nelson Investment Management L.P.’s holdings in UnitedHealth Group were worth $497,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Robbins Farley purchased a new stake in UnitedHealth Group in the 3rd quarter valued at $25,000. NewSquare Capital LLC raised its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Strategic Investment Solutions Inc. IL purchased a new stake in UnitedHealth Group in the 1st quarter valued at $35,000. WFA of San Diego LLC purchased a new stake in UnitedHealth Group in the 2nd quarter valued at $39,000. Finally, Annapolis Financial Services LLC increased its position in shares of UnitedHealth Group by 38.6% during the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after purchasing an additional 22 shares during the last quarter. 85.69% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. HSBC reaffirmed a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Jefferies Financial Group decreased their target price on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a research report on Monday, November 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Tuesday, January 16th. UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $520.00 to $640.00 in a research note on Monday, October 16th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $575.79.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 0.4 %

Shares of NYSE UNH opened at $518.22 on Friday. The company has a market cap of $479.31 billion, a P/E ratio of 21.74, a P/E/G ratio of 1.41 and a beta of 0.54. The company has a quick ratio of 0.80, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The business has a 50-day simple moving average of $525.36 and a two-hundred day simple moving average of $517.77. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter last year, the company posted $5.34 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.